AKT1 and cancer: This suppresses AKT (Protein kinase B) phosphorylation thereby deactivating the phosphatidylinositol 3-kinase (PI3K)/AKT signaling(Yakes et al., 2002) pathway This pathway is highly activated in various types of cancer(Nicholson and Anderson 2002; Carmona et al., 2016).